These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19032173)

  • 1. Inhibition of flucloxacillin tubular renal secretion by piperacillin.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Sörgel F
    Br J Clin Pharmacol; 2008 Nov; 66(5):648-59. PubMed ID: 19032173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile.
    Landersdorfer CB; Bulitta JB; Kirkpatrick CM; Kinzig M; Holzgrabe U; Drusano GL; Stephan U; Sörgel F
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5715-23. PubMed ID: 22908169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
    Gath J; Charles B; Sampson J; Smithurst B
    J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence.
    Barker CIS; Kipper K; Lonsdale DO; Wright K; Thompson G; Kim M; Turner MA; Johnston A; Sharland M; Standing JF
    J Antimicrob Chemother; 2023 Sep; 78(9):2148-2161. PubMed ID: 37531085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
    Udy AA; Lipman J; Jarrett P; Klein K; Wallis SC; Patel K; Kirkpatrick CM; Kruger PS; Paterson DL; Roberts MS; Roberts JA
    Crit Care; 2015 Jan; 19(1):28. PubMed ID: 25632974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimens.
    Bulitta JB; Kinzig M; Jakob V; Holzgrabe U; Sörgel F; Holford NH
    Br J Clin Pharmacol; 2010 Nov; 70(5):682-93. PubMed ID: 21039762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
    Imani S; Buscher H; Marriott D; Gentili S; Sandaradura I
    J Antimicrob Chemother; 2017 Oct; 72(10):2891-2897. PubMed ID: 29091190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new similarity method for assessment of pharmacokinetic interaction between flucloxacillin and midazolam.
    Fan Q; Liu W; Yang Y; Zhou J; Tang Y; Xiao M; Pan X; Zhou Y; Deng K; He F
    Pharmazie; 2019 Jul; 74(7):397-405. PubMed ID: 31288895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
    Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
    J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified oral flucloxacillin absorption test for patients requiring long-term treatment.
    Dijkmans AC; Hartigh Jd; van Dissel JT; Burggraaf J
    Ther Drug Monit; 2012 Jun; 34(3):356-8. PubMed ID: 22569354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
    Dhaese SAM; Roberts JA; Carlier M; Verstraete AG; Stove V; De Waele JJ
    Int J Antimicrob Agents; 2018 Apr; 51(4):594-600. PubMed ID: 29277531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.
    Strenkoski-Nix LC; Forrest A; Schentag JJ; Nix DE
    J Clin Pharmacol; 1998 Nov; 38(11):1063-71. PubMed ID: 9824789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.
    Kipper K; Barker CIS; Standing JF; Sharland M; Johnston A
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.
    Nauta EH; Mattie H
    Br J Clin Pharmacol; 1975 Apr; 2(2):111-21. PubMed ID: 1234495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.